UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.12B |
| 2 |
Apple
AAPL
|
+$1.08B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
Nike
NKE
|
+$1.03B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$821M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$389M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$383M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$348M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$263M |
| 5 |
NRG Energy
NRG
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.8% |
| 2 | Financials | 8.25% |
| 3 | Healthcare | 6.4% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Communication Services | 4.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MPV
4076
Barings Participation Investors
MPV
$176M
| $1.43M | ﹤0.01% |
86,851
+50,332
| +138% | +$792K |
|
|
URG
4077
Ur-Energy
URG
$552M
| $1.43M | ﹤0.01% |
1,024,294
+149,496
| +17% | +$248K |
|
4078
Towne Bank
TOWN
$3.42B
| $1.43M | ﹤0.01% |
52,542
-38,360
| -42% | -$1.03M |
|
4079
PRA Group
PRAA
$706M
| $1.43M | ﹤0.01% |
72,629
+13,047
| +22% | +$300K |
|
4080
Bausch Health
BHC
$2.33B
| $1.43M | ﹤0.01% |
204,785
+69,671
| +52% | +$527K |
|
4081
Civeo
CVEO
$337M
| $1.43M | ﹤0.01% |
57,267
-1,490
| -3% | -$37.1K |
|
4082
Global X SuperIncome Preferred ETF
SPFF
$142M
| $1.43M | ﹤0.01% |
154,926
-16,461
| -10% | -$151K |
|
4083
Upwork
UPWK
$1.03B
| $1.43M | ﹤0.01% |
132,694
-77,411
| -37% | -$878K |
|
4084
Urban Outfitters
URBN
$6.8B
| $1.43M | ﹤0.01% |
34,725
-19,951
| -36% | -$820K |
|
4085
State Street SPDR S&P Emerging Markets Small Cap ETF
EWX
$693M
| $1.43M | ﹤0.01% |
24,609
-56
| -0.2% | -$3.21K |
|
4086
Southside Bancshares
SBSI
$965M
| $1.42M | ﹤0.01% |
51,593
-3,419
| -6% | -$92.7K |
|
4087
Lakeland Financial Corp
LKFN
$1.54B
| $1.42M | ﹤0.01% |
23,115
-3,943
| -15% | -$240K |
|
4088
PUT
The Mosaic Company
MOS
$7.34B
| $1.42M | ﹤0.01% |
+49,200
| New | +$1.48M |
|
4089
CALL
State Street
STT
$51.4B
| $1.42M | ﹤0.01% |
19,200
-29,000
| -60% | -$2.16M |
|
|
IFLN
4090
Invesco Bloomberg Enhanced Fallen Angels ETF
IFLN
$306M
| $1.42M | ﹤0.01% |
79,056
-5,591
| -7% | -$100K |
|
4091
Camden National
CAC
$982M
| $1.42M | ﹤0.01% |
43,025
-10,266
| -19% | -$324K |
|
4092
Quanex
NX
$1.01B
| $1.42M | ﹤0.01% |
51,232
-50,866
| -50% | -$1.68M |
|
4093
CALL
KE Holdings
BEKE
$18.7B
| $1.42M | ﹤0.01% |
100,000
-262,200
| -72% | -$4.11M |
|
|
MORF
4094
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $1.41M | ﹤0.01% |
41,460
-107,534
| -72% | -$3.19M |
|
|
HIMX
4095
Himax Technologies
HIMX
$2.61B
| $1.41M | ﹤0.01% |
177,883
-1,042,311
| -85% | -$6.38M |
|
4096
CALL
Diageo
DEO
$52.8B
| $1.41M | ﹤0.01% |
+11,200
| New | +$1.54M |
|
4097
4D Molecular Therapeutics
FDMT
$600M
| $1.41M | ﹤0.01% |
67,140
-307,050
| -82% | -$7.7M |
|
|
PMT
4098
PennyMac Mortgage Investment
PMT
$824M
| $1.41M | ﹤0.01% |
102,289
-32,686
| -24% | -$458K |
|
4099
CALL
Cardiff Oncology
CRDF
$81.7M
| $1.41M | ﹤0.01% |
633,000
| – | – |
|
4100
CALL
Viking Therapeutics
VKTX
$3.94B
| $1.4M | ﹤0.01% |
+26,500
| New | +$1.74M |
|
Similar funds
UBS Group's Q2 2024 Portfolio in Review
As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
UBS Group's Q2 2024 filing shows 1,231 new, 3,688 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
- UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
- UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
- UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
- UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
- UBS Group opened 1,231 new positions and closed 1,043 in Q2 2024.
- UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.
Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.